Shire selling four tranche US dollar bond for Baxalta buy :lead
By Mike Gambale
NEW YORK, Sept 19 (IFR) - Here is the pricing progression on
the new bond offering from drugmaker Shire (Hamburg: 3979575.HM - news) (Baa3/BBB-) to help
finance its acquisition of Baxalta (Berlin: 9BX.BE - news) , one of the banks leading the
deal told IFR.
The deal is expected to price later on Monday.
SIZE MATURITY IPTs (T+)
TBD 3yr FXD 120-125bp
TBD 5yr FXD 140-145bp
TBD 7yr FXD 160-165bp
TBD 10yr FXD 175-180bp
Active bookrunners: Bank of America Merrill Lynch, Barclays (LSE: BARC.L - news) ,
Morgan Stanley (Xetra: 885836 - news)
(Reporting by Mike Gambale; Editing by Natalie Harrison and
Marc Carnegie)